These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Abnormal FDG and MIBG Activity in the Bones in a Patient With Neuroblastoma Without Detectable Primary Tumor. Zhang W; Zhuang H; Servaes S Clin Nucl Med; 2016 Aug; 41(8):632-3. PubMed ID: 26825196 [TBL] [Abstract][Full Text] [Related]
6. Diagnosis, Treatment Response, and Prognosis: The Role of Piccardo A; Morana G; Puntoni M; Campora S; Sorrentino S; Zucchetta P; Ugolini M; Conte M; Cistaro A; Ferrarazzo G; Pescetto M; Lattuada M; Bottoni G; Garaventa A; Giovanella L; Lopci E J Nucl Med; 2020 Mar; 61(3):367-374. PubMed ID: 31541036 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of 18F-FDG PET/CT in paediatric neuroblastoma: comparison with 131I-MIBG scintigraphy. Dhull VS; Sharma P; Patel C; Kundu P; Agarwala S; Bakhshi S; Bhatnagar V; Bal C; Kumar R Nucl Med Commun; 2015 Oct; 36(10):1007-13. PubMed ID: 26049371 [TBL] [Abstract][Full Text] [Related]
8. Benign differentiation of treated neuroblastoma as a cause of false positive by Garcia JR; Bassa P; Soler M; Jaramillo A; Ortiz S; Riera E Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(6):389-390. PubMed ID: 31000447 [No Abstract] [Full Text] [Related]
9. The new international neuroblastoma response criteria. Orr KE; McHugh K Pediatr Radiol; 2019 Oct; 49(11):1433-1440. PubMed ID: 31620844 [TBL] [Abstract][Full Text] [Related]
10. ¹²³I-MIBG scintigraphy/SPECT versus ¹⁸F-FDG PET in paediatric neuroblastoma. Melzer HI; Coppenrath E; Schmid I; Albert MH; von Schweinitz D; Tudball C; Bartenstein P; Pfluger T Eur J Nucl Med Mol Imaging; 2011 Sep; 38(9):1648-58. PubMed ID: 21617976 [TBL] [Abstract][Full Text] [Related]
11. Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastoma. Taggart DR; Han MM; Quach A; Groshen S; Ye W; Villablanca JG; Jackson HA; Mari Aparici C; Carlson D; Maris J; Hawkins R; Matthay KK J Clin Oncol; 2009 Nov; 27(32):5343-9. PubMed ID: 19805691 [TBL] [Abstract][Full Text] [Related]
12. [Neuroblastoma staging: discrepancies between ¹⁸F-FDG-PET and ¹²³I-MIBG]. Mena LM; Muros MA; Palacios H; Moreno MJ; Santiago A; Llamas JM An Pediatr (Barc); 2010 Dec; 73(6):363-4. PubMed ID: 20817583 [No Abstract] [Full Text] [Related]
13. Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting. Park JR; Bagatell R; Cohn SL; Pearson AD; Villablanca JG; Berthold F; Burchill S; Boubaker A; McHugh K; Nuchtern JG; London WB; Seibel NL; Lindwasser OW; Maris JM; Brock P; Schleiermacher G; Ladenstein R; Matthay KK; Valteau-Couanet D J Clin Oncol; 2017 Aug; 35(22):2580-2587. PubMed ID: 28471719 [TBL] [Abstract][Full Text] [Related]
14. [ Samim A; Blom T; Poot AJ; Windhorst AD; Fiocco M; Tolboom N; Braat AJAT; Viol SLM; van Rooij R; van Noesel MM; Lam MGEH; Tytgat GAM; de Keizer B Eur J Nucl Med Mol Imaging; 2023 Mar; 50(4):1146-1157. PubMed ID: 36504277 [TBL] [Abstract][Full Text] [Related]
15. [ Wang P; Li T; Liu Z; Jin M; Su Y; Zhang J; Jing H; Zhuang H; Li F Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):3097-3106. PubMed ID: 37160439 [TBL] [Abstract][Full Text] [Related]